← SynDRA
VADIMEZAN
SynDRA canonical compound SYN0003089 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
|---|
| Mechanism of action | angiogenesis inhibitor |
|---|
All known targets
- NFKB1; NFKB2; RELA; RELB; REL
Mechanisms of action (all sources)
- angiogenesis inhibitor
- Modulator
Drug classes
Cross-references
Synonyms
- AS-1404
- ASA-404
- ASA404
- DMXAA
- NSC-640488
- R-1564
- 5,6-MeXAA
- 5,6-dimethylxanthenone-4-acetic acid
- 5,6-Mexaa
- 2-(5,6-dimethyl-9-oxo-9H-xanthen-4-yl)acetic acid
- AS 1404
- 5,6-Dimethylxanthenone-4-Acetic Acid
- ASA 404
- NSC 640488
- 5,6-dimethylxanthenoneacetic acid
- Dimethyloxoxanthene acetic acid
- 5,6-Dimethyl-9-oxo-9H-xanthene-4-acetic acid
- 9H-Xanthene-4-acetic acid, 5,6-dimethyl-9-oxo-
- vadimezanum
- 5,6-Dimethyl xanthenone acetic acid
- CHEBI:75934
- (5,6-dimethyl-9-oxoxanthen-4-yl)acetic acid
- 5,6-MexXAA
- RefChem:193484
- dimethylxanthenone acetic acid
- DTXCID0020949
- NSC640488
- DMXAA (Vadimezan)
- 5,6-Dimethylxantheonone-4-acetic Acid
- 9H-Xanthene-4-aceticacid, 5,6-dimethyl-9-oxo-
- Vadimezan [INN]
- (5,6-Dimethyl-9-oxo-xanthen)-4-acetic acid
- Vadimezan (DMXAA)
- (5,6-dimethyl-9-oxo-9H-xanthen-4-yl)acetic acid
- MFCD00870555
- 2-(5,6-dimethyl-9-oxoxanthen-4-yl)acetic acid
- (5,6-Dimethyl-9-oxo-9H-xanthen-4-yl)-acetic acid
- 6-MeXAA
- AS1404
Look up VADIMEZAN in the interactive SynDRA portal →